Effects of interleukin-13 and montelukast on the expression of zonula occludens-1 in human podocytes
about
Pathogenesis of minimal change nephrotic syndrome: an immunological conceptLncRNA MALAT1 is dysregulated in diabetic nephropathy and involved in high glucose-induced podocyte injury via its interplay with β-catenin.Montelukast improves the changes of cytoskeletal and adaptor proteins of human podocytes by interleukin-13.Montelukast as an add-on treatment in steroid dependant nephrotic syndrome, randomised-controlled trial.
P2860
Effects of interleukin-13 and montelukast on the expression of zonula occludens-1 in human podocytes
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Effects of interleukin-13 and ...... occludens-1 in human podocytes
@ast
Effects of interleukin-13 and ...... occludens-1 in human podocytes
@en
type
label
Effects of interleukin-13 and ...... occludens-1 in human podocytes
@ast
Effects of interleukin-13 and ...... occludens-1 in human podocytes
@en
prefLabel
Effects of interleukin-13 and ...... occludens-1 in human podocytes
@ast
Effects of interleukin-13 and ...... occludens-1 in human podocytes
@en
P2093
P2860
P1476
Effects of interleukin-13 and ...... occludens-1 in human podocytes
@en
P2093
Jae Il Shin
Moin A Saleem
Se Jin Park
Tae-Sun Ha
P2860
P304
P356
10.3349/YMJ.2015.56.2.426
P577
2015-03-01T00:00:00Z